A More Viable Way To Invest In Top-Performing Biotech Stocks

Biotechnology stocks are on track to beat the stock market for a remarkable fifth year straight.  The largest biotech exchange-traded fund, iShares Nasdaq Biotechnology ETF (IBB), with more than $9 billion in assets, rallied an average of 36% the past five years vs. 10.4% for the SPDR S&P 500 ETF (SPY) have a peek at this website. […]

Source: www.forbes.com



Comments are closed.